AnalystsMike MatsonMike Matson's Stock Forecasts
AnalystsMike Matson
Analyst Ranking
Bottom 3%
#4752 out of 4861 analysts
Average Return
-2.75%
Win Rate
39%168 out of 427
Risk vs Reward
Poor
Good
Mike Matson's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Personalis IncPSNL | +269.23% | $1.17 | $4.32 | 2023-11-08 - 2024-11-07 | Buy |
Personalis IncPSNL | +210.28% | $2.14 | $6.64 | 2024-01-05 - 2025-01-03 | Buy |
Personalis IncPSNL | +173.55% | $1.55 | $4.24 | 2024-02-29 - 2025-02-27 | Buy |
Personalis IncPSNL | +161.48% | $1.22 | $3.19 | 2024-06-21 - 2025-04-17 | Buy |
Cantel Medical CorpCMD | +158.06% | $31.93 | $82.40 | 2020-05-12 - 2021-01-13 | Buy |
Mike Matson Analyst Color
Get additional color on Mike Matson's coverage of popular stocks
Mike Matson's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Boston Scientific CorpBSX | 22 | Buy | $113.00 | +18.80% | Upgrades | 6 days ago |
Lucid Diagnostics IncLUCD | 18 | Buy | $3.00 | +147.93% | Reiterates | 11 days ago |
Personalis IncPSNL | 20 | Buy | $7.00 | +119.44% | Reiterates | 12 days ago |
Merit Medical Systems IncMMSI | 25 | Buy | $116.00 | +27.63% | Reiterates | 12 days ago |
Orthopediatrics CorpKIDS | 19 | Buy | $42.00 | +100.00% | Reiterates | 12 days ago |
Enovis CorpENOV | 14 | Buy | $64.00 | +100.25% | Reiterates | 12 days ago |
Oncocyte CorpOCX | 17 | Buy | $4.25 | +49.65% | Reiterates | 13 days ago |
Atricure IncATRC | 29 | Buy | $51.00 | +59.33% | Reiterates | a month ago |
Stryker CorpSYK | 7 | Buy | $442.00 | +27.56% | Reiterates | a month ago |
Haemonetics CorpHAE | 10 | Buy | $104.00 | +81.91% | Maintains | a month ago |
Livanova PLCLIVN | 25 | Buy | $64.00 | +79.88% | Reiterates | a month ago |
Artivion IncAORT | 21 | Buy | $32.00 | +39.56% | Maintains | 2 months ago |
Veracyte IncVCYT | 16 | Buy | $51.00 | +63.78% | Reiterates | 2 months ago |
Neogenomics IncNEO | 23 | Buy | $18.00 | +88.48% | Maintains | 2 months ago |
Conmed CorpCNMD | 22 | Buy | $91.00 | +87.28% | Maintains | 3 months ago |
Hologic IncHOLX | 15 | Hold | $90.00 | +56.36% | Downgrades | 3 months ago |
Paragon 28 IncFNA | 16 | Hold | $13.00 | -0.69% | Downgrades | 3 months ago |
Transmedics Group IncTMDX | 4 | Hold | $109.00 | +23.53% | Downgrades | 5 months ago |
Resmed IncRMD | 10 | Hold | $236.00 | +10.84% | Downgrades | 8 months ago |
Surmodics IncSRDX | 14 | Buy | $43.00 | +55.97% | Maintains | a year ago |
Inari Medical IncNARI | 4 | Buy | $57.00 | -28.72% | Maintains | a year ago |
Shockwave Medical IncSWAV | 6 | Buy | $286.00 | N/A | Maintains | a year ago |
Masimo CorpMASI | 12 | Buy | $86.00 | N/A | Maintains | a year ago |
Axonics IncAXNX | 15 | Buy | $63.00 | N/A | Maintains | a year ago |
Inogen IncINGN | 7 | Buy | $26.00 | N/A | Reiterates | 2 years ago |
Teleflex IncTFX | 4 | Buy | $291.00 | N/A | Reiterates | 2 years ago |
Penumbra IncPEN | 4 | Buy | $300.00 | N/A | Maintains | 2 years ago |
Inmode LtdINMD | 8 | Buy | $60.00 | N/A | Reiterates | 2 years ago |
Steris PLCSTE | 6 | Hold | N/A | N/A | Downgrades | 3 years ago |
Medtronic PLCMDT | 7 | Hold | N/A | N/A | Downgrades | 3 years ago |
Zimmer Biomet Holdings IncZBH | 15 | Hold | N/A | N/A | Downgrades | 3 years ago |
Cardiovascular Systems IncCSII | 4 | Hold | N/A | N/A | Downgrades | 3 years ago |
Invacare CorpIVCRQ | 1 | Buy | $8.00 | N/A | Maintains | 4 years ago |
Genmark Diagnostics IncGNMK | 3 | Hold | N/A | N/A | Downgrades | 4 years ago |
Si Bone IncSIBN | 1 | Buy | $34.00 | N/A | Maintains | 4 years ago |
Globus Medical IncGMED | 1 | Buy | $75.00 | N/A | Maintains | 4 years ago |
Cantel Medical CorpCMD | 2 | Hold | N/A | N/A | Downgrades | 4 years ago |
Hill Rom Holdings IncHRC | 3 | Hold | N/A | N/A | Downgrades | 4 years ago |
Nuvasive IncNUVA | 1 | Buy | $74.00 | N/A | Upgrades | 5 years ago |
Wright Medical Group NvWMGI | 1 | Hold | N/A | N/A | Downgrades | 5 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.